Analysis CARE Ratings Limited (CARERATING)
6/2/2024
Analysis of CARE Ratings Limited (CARERATING)
CARE Ratings Limited has been showing a downward trend in the recent days. The closing prices have been decreasing gradually from 1105.70 on May 18th to 1010.10 on May 31st. The Relative Strength Index (RSI) values have been consistently below 50, indicating a bearish momentum in the stock.The Moving Average Convergence Divergence (MACD) indicator has been negative, with the MACD line consistently below the signal line. This further confirms the bearish sentiment in the stock.
Overall, based on the RSI, MACD, and the decreasing closing prices, it seems that CARE Ratings Limited is currently in a bearish phase. Traders and investors may want to exercise caution and closely monitor the stock for any potential reversal in the trend.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow TTM of $110.56 billion and levered free cash flow TTM of $84.73 billion. The balance sheet shows a total cash MRQ of $67.15 billion, total debt MRQ of $104.59 billion, and a current ratio MRQ of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The income statement reveals EBITDA of $131.39 billion, revenue TTM of $381.62 billion, and a diluted EPS TTM of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, float shares of 15.31 billion, and shares short of 99.29 million. The stock has outstanding shares of 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book MRQ of 39.34 and price to sales TTM of 7.65. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, and 200-day moving average of $181.04. The 52-week low is $164.08, the 52-week high is $199.62, and the 52-week change is 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same period last year. The number of analysts providing estimates is 25.
Looking at the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate for total sales is $357,772,000,000, showing a 1% growth compared to the previous fiscal year. The number of analysts providing estimates increases to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate further increases to $380,772,000,000, with a significant growth rate of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly increasing number of analysts providing forecasts.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of approximately 9.7%.
- However, when looking at the past 5 years, the company had a higher growth rate of around 20.1% per annum.
Overall, it seems that the company is expected to maintain a solid growth trajectory, although at a slightly lower rate compared to the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is $191.57, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From the data, we can observe the following trends:
1. The company experienced a significant increase in revenue from 2020 to 2021, followed by a slight decrease in 2023 compared to 2022.
2. Despite the slight decrease in 2023, the revenue figures remain relatively high compared to the base year of 2020.
3. Overall, the company has shown growth in revenue over the past four years, indicating a positive trend in its sales performance.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and accounts receivable, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist of investments, machinery, furniture, and equipment, which have been steadily increasing.
4. Total liabilities have also been increasing, with a significant rise from 2022 to 2023.
5. Shareholders' equity has shown fluctuations but has generally been on an upward trend.
6. The company has been investing in leases, land, and improvements, indicating a focus on long-term growth.
7. The company has been managing its debt levels, with both short-term and long-term debt showing variations over the years.
8. The provision for risks and charges has also been fluctuating, indicating changes in the company's risk management strategies.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast suggests a slight improvement from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
MACD of CARERATING
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
